News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Reata Pharmaceuticals Announces Positive Results from Pivotal Study of Omaveloxolone in FA

By Jeanene Swanson | October 30, 2019
Blog Post

Capricor Therapeutics Announces Positive Interim Results from Phase 2 Study of CAP-1002 to Treat DMD

By Jeanene Swanson | October 29, 2019
Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019
Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

By MDA Staff | October 15, 2019
Blog Post

Casey’s General Stores Round Up for MDA

By MDA Staff | October 15, 2019
Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | October 7, 2019
Blog Post

MDA Awards Clinical Research Network Grant to CMT Researcher Michael Shy for Inherited Neuropathies Consortium

By Jeanene Swanson | September 27, 2019
MDA logo
Blog Post

In a Letter to the Duchenne Community, Santhera Announces Positive Results of Phase 2 Vamorolone Study, EMA’s Review of Puldysa to Treat Symptoms of DMD

By MDA Staff | September 26, 2019
Blog Post

MDA Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research

By Jeanene Swanson | September 5, 2019